Skip to main content
. 2020 Nov 14;20:284. doi: 10.1186/s12871-020-01200-w

Table 1.

Baseline characteristics of study patients (n = 38)

Variable Category Mean ± SD
Number (%)
Age (years) 64.8 ± 6.4
Sex Female 16 (42.1)
Male 22 (57.9)
BMI (kg/m2) (n = 37) 28.8 ± 5.7
Education level < High school 15 (39.5)
High school 17 (44.7)
Undergraduate degree 4 (10.5)
Graduate Degree 1 (2.6)
Postgraduate degree 1 (2.6)
No. of languages known 1 20 (52.6)
2 11 (28.9)
3 6 (15.8)
6 1 (2.6)
Working No 30 (78.9)
Yes 8 (21.1)
Marital status Married 25 (65.8)
Divorced 8 (21.1)
Widow 5 (13.2)
Self-sufficient No 3 (7.9)
Yes 35 (92.1)
Living environment (No. of people) 1 12 (31.6)
2 24 (63.2)
3 1 (2.6)
4 1 (2.6)
Number of alcoholic drinks/weeks 0 22 (57.9)
1 6 (15.8)
≥ 2 10 (26.3)
Smoking Status Non-smoker 15 (39.5)
Past smoker 14 (36.8)
(Mean no. of years since quitting) 13.1 ± 12.2
Current smoker 9 (23.7)
(Mean no. of cigarettes/day) 12.2 ± 7.3
Surgery General 12 (31.6)
Genitourinary 15 (39.5)
Orthopedic 11 (28.9)
No. of psychoactive drugs 0 32 (84.2)
1 5 (13.2)
2 1 (2.6)
Type of psychoactive drug (n = 6) Benzodiazepines 5 (83.3)
SSRI 1 (16.7)
Type 2 diabetes No 28 (73.7)
Yes 10 (26.3)
IPAQ work-related (h/week) 0.26 ± 0.92
IPAQ transport-related (h/day) 0.63 ± 0.76
IPAQ household-related (h/day) 0.42 ± 0.60
IPAQ leisure time-related (h/day) 0.19 ± 0.41
IPAQ sitting time (h/day) 7.3 ± 2.4
Energy (METs-min) 239 ± 242
GDS (0–30) 6.66 ± 4.43
MMSE (/30) 25.8 ± 4.19
IL-6 (pg/ml) (n = 31) 31.2 ± 33.9
HMGB1 (pg/ml) (n = 33) 38.9 ± 85.6

BMI Body mass index, SSRI Selective serotonin reuptake inhibitor, MMSE Mini-mental state examination, IPAQ International Physical Activity Questionnaire (long version), IL Interleukin, HMGB1 High molecular group box protein 1, METs Metabolic Equivalents, GDS Geriatric depression scale